ASTRAZENECA PHARMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 ,inter alia, to consider and approve The Unaudited Financial Results of the Company for the quarter ended June 30, 2024.
We would also like to inform you that the 'Trading Window' remains closed for all Designated Persons, from June 16, 2024 to August 10, 2024 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.
We request you to please take the same on record.
|